CLEVELAND, Ohio — In less than a year, the Cleveland Clinic’s $1 billion Neurological Institute will bring specialists who ...

The $1.1 billion building will be the largest on Cleveland Clinic's main campus and introduces technology that doesn't yet ...

Collaboration expands access to innovative gait rehabilitation and fall prevention solutions, combining technology and ...

Subscribe to the Wake Up, cleveland.com’s free morning newsletter, delivered to your inbox weekdays at 5:30 a.m. More than ...

By Dr. Liji Thomas, MD By merging voice instability, gait asymmetry, and tremor-driven handwriting changes into a single explainable AI framework, researchers show how digital biomarkers can move ...

In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...

Balance and coordination problems on stairs can be an early sign of dementia, according to leading charities Alzheimer ...

This rare and devastating genetic disease can now be effectively treated with haploidentical stem cell transplantation.

AEW star Rebel has shared an emotional health update about her pulmonary lymphoma diagnosis. Last year in November, Rebel, whose real name is Tanea Brooks, shared that she was diagnosed with primary ...

Interim analysis of Phase 1b clinical study of GT-02287, including biomarker and clinical endpoints, will be presented in oral symposiumCompany ...

A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

Kneu Health, a precision neurology platform transforming care for Parkinson's and dementia, today announced at the HIMSS Global Health Conference & Exhibition results from a six-month clinical ...